RxDoctor Payments Data

Raven Aravind

Acute Care · Dallas, TXNPI 1518592534

Payments from drug & device makers

$1,600in general payments, 2019–2025

Across 69 payments — averaging $23.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$332
  • Johnson & Johnson$157
  • Pfizer$89
  • Amgen$85
  • Astellas Pharma US Inc$81
  • Novartis$80
  • plus $777 from 23 others

What the payments were for

  • Food & beverage$1,22276%
  • Education$37824%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,600 in reported general payments places this provider in the 75th percentile of 2,323 acute care providers in Texas.

See all acute care providers in Texas

Other acute care in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →